ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,298
-22.4%
28,230
-3.0%
0.00%0.0%
Q2 2023$1,672
-40.0%
29,099
-60.8%
0.00%
-50.0%
Q1 2023$2,785
-40.1%
74,274
-55.3%
0.00%
-42.9%
Q4 2022$4,652
-99.9%
166,040
-17.4%
0.01%
-12.5%
Q3 2022$5,650,000
-46.7%
201,065
-34.0%
0.01%
-46.7%
Q2 2022$10,600,000
-24.6%
304,672
-22.2%
0.02%
-16.7%
Q1 2022$14,058,000
+45.1%
391,585
-5.9%
0.02%
+50.0%
Q4 2021$9,690,000
+156.8%
416,049
+109.6%
0.01%
+140.0%
Q3 2021$3,773,000
+28.2%
198,472
+36.0%
0.01%
+25.0%
Q2 2021$2,942,000
+187.3%
145,918
+161.2%
0.00%
+300.0%
Q1 2021$1,024,000
-89.8%
55,869
-89.3%
0.00%
-95.7%
Q4 2019$10,050,000
+11.7%
520,984
+14.8%
0.02%
+9.5%
Q3 2019$9,000,000
+156.3%
453,835
+172.9%
0.02%
+162.5%
Q2 2019$3,511,000
+14.1%
166,302
+10.5%
0.01%
+14.3%
Q1 2019$3,076,000
+478.2%
150,541
+332.1%
0.01%
+600.0%
Q2 2018$532,00034,8400.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders